Primary Care POC Diagnostics Market Size, Share & Trends Report

Primary Care POC Diagnostics Market Size, Share & Trends Analysis Report By Product (Glucose Testing, Lipid Testing, Drug Abuse Testing), By End-use (Pharmacy & Retail Clinics, Physician Office), By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-2-68038-333-1
  • Number of Pages: 192
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                       1.1.1. Product
                       1.1.2. End use
                       1.1.3. Regional scope
                       1.1.4. Estimates and forecast timeline
                   1.2. Research Methodology
                   1.3. Information Procurement
                       1.3.1. Purchased database
                       1.3.2. GVR’s internal database
                       1.3.3. Secondary sources
                       1.3.4. Primary research
                       1.3.5. Details of primary research
                   1.4. Information or Data Analysis
                   1.5. Market Formulation & Validation
                   1.6. Model Details
                   1.7. List of Secondary Sources
                   1.8. List of Primary Sources
                   1.9. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Product outlook
                       2.2.2. End use outlook
                       2.2.3. Regional outlook
                   2.3. Competitive Insights
Chapter 3. Primary Care POC Diagnostics Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Penetration & Growth Prospect Mapping
                   3.3. Market Dynamics
                       3.3.1. Market driver analysis
                       3.3.2. Market restraint analysis
                   3.4. Primary Care POC Diagnostics Market Analysis Tools
                       3.4.1. Industry Analysis - Porter’s
                           3.4.1.1. Supplier power
                           3.4.1.2. Buyer power
                           3.4.1.3. Substitution threat
                           3.4.1.4. Threat of new entrant
                           3.4.1.5. Competitive rivalry
                       3.4.2. PESTEL Analysis
                           3.4.2.1. Political landscape
                           3.4.2.2. Technological landscape
                           3.4.2.3. Economic landscape
Chapter 4. Primary Care POC Diagnostics: Product Estimates & Trend Analysis
                   4.1. Primary Care POC Diagnostics Market: Key Takeaways
                   4.2. Primary Care POC Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
                   4.3. Glucose Testing
                       4.3.1. Glucose Testing market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.4. Hb1Ac Testing
                       4.4.1. Hb1Ac testing market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.5. 4.5. Autoimmune Disease
                       4.5.1. Autoimmune Disease market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.6. Coagulation
                       4.6.1. Coagulation market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.7. Fertility
                       4.7.1. Fertility market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.8. Infectious Diseases
                       4.8.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.9. Cardiac Markers
                       4.9.1. Cardiac markers market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.10. Thyroid Stimulating Hormone
                       4.10.1. Thyroid stimulating hormone market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.11. Hematology
                       4.11.1. Hematology market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.12. Primary Care Systems
                       4.12.1. Primary care systems market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.13. Decentralized Clinical Chemistry
                       4.13.1. Decentralized clinical chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.14. Feces
                       4.14.1. Feces market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.15. Lipid Testing
                       4.15.1. Lipid testing market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.16. Cancer Markers
                       4.16.1. Cancer markers market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.17. Blood Gas/Electrolytes
                       4.17.1. Blood gas/electrolytes market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.18. Ambulatory Chemistry
                       4.18.1. Ambulatory chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.19. Drug Abuse Testing
                       4.19.1. Drug abuse testing market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.20. Urinalysis
                       4.20.1. Urinalysis market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Primary Care POC Diagnostics: End Use Estimates & Trend Analysis
                   5.1. Primary Care POC Diagnostics Market: Key Takeaways
                   5.2. Primary Care POC Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
                   5.3. Pharmacy & Retail Clinics
                       5.3.1. Pharmacy & Retail Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.4. Physician office
                       5.4.1. Physician office market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.5. Urgent Care Clinics
                       5.5.1. Urgent care clinics market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.6. Non-practice Clinics
                       5.6.1. Non-practice clinics market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Primary Care POC Diagnostics Market: Regional Estimates & Trend Analysis
                   6.1. Regional Outlook
                   6.2. Primary Care POC Diagnostics Market by Region: Key Marketplace Takeaway
                   6.3. North America
                       6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.3.2. U.S.
                           6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.3.3. Canada
                           6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                   6.4. Europe
                       6.4.1. UK
                           6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.4.2. Germany
                           6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.4.3. France
                           6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.4.4. Italy
                           6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.4.5. Spain
                           6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.4.6. Sweden
                           6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.4.7. Norway
                           6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.4.8. Denmark
                           6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                   6.5. Asia Pacific
                       6.5.1. Japan
                           6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.5.2. China
                           6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.5.3. India
                           6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.5.4. Australia
                           6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.5.5. Thailand
                           6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.5.6. South Korea
                           6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                   6.6. Latin America
                       6.6.1. Brazil
                           6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.6.2. Mexico
                           6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.6.3. Argentina
                           6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                   6.7. MEA
                       6.7.1. Saudi Arabia
                           6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.7.2. South Africa
                           6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.7.3. UAE
                           6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.7.4. Kuwait
                           6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
                   7.1. Recent Developments & Impact Analysis, By Key Market Participants
                   7.2. Market Participant Categorization
                       7.2.1. F Hoffmann-La Roche Ltd.
                           7.2.1.1. Company overview
                           7.2.1.2. Financial performance
                           7.2.1.3. Product benchmarking
                           7.2.1.4. Strategic initiatives
                       7.2.2. Danaher
                           7.2.2.1. Company overview
                           7.2.2.2. Financial performance
                           7.2.2.3. Product benchmarking
                           7.2.2.4. Strategic initiatives
                       7.2.3. Abbott
                           7.2.3.1. Company overview
                           7.2.3.2. Financial performance
                           7.2.3.3. Product benchmarking
                           7.2.3.4. Strategic initiatives
                       7.2.4. Siemens Healthineers
                           7.2.4.1. Company overview
                           7.2.4.2. Financial performance
                           7.2.4.3. Product benchmarking
                           7.2.4.4. Strategic initiatives
                       7.2.5. bioMerieux SA
                           7.2.5.1. Company overview
                           7.2.5.2. Financial performance
                           7.2.5.3. Product benchmarking
                           7.2.5.4. Strategic initiatives
                       7.2.6. Abaxis
                           7.2.6.1. Company overview
                           7.2.6.2. Financial performance
                           7.2.6.3. Product benchmarking
                           7.2.6.4. Strategic initiatives
                       7.2.7. QIAGEN
                           7.2.7.1. Company overview
                           7.2.7.2. Financial performance
                           7.2.7.3. Product benchmarking
                           7.2.7.4. Strategic initiatives
                       7.2.8. Johnson & Johnson Services, Inc.
                           7.2.8.1. Company overview
                           7.2.8.2. Financial performance
                           7.2.8.3. Product benchmarking
                           7.2.8.4. Strategic initiatives
                       7.2.9. Nova Biomedical
                           7.2.9.1. Company overview
                           7.2.9.2. Financial performance
                           7.2.9.3. Product benchmarking
                           7.2.9.4. Strategic initiatives
                       7.2.10. Instrumentation Laboratory
                           7.2.10.1. Company overview
                           7.2.10.2. Financial performance
                           7.2.10.3. Product benchmarking
                           7.2.10.4. Strategic initiatives
                       7.2.11. Trividia Health, Inc.
                           7.2.11.1. Company overview
                           7.2.11.2. Financial performance
                           7.2.11.3. Product benchmarking
                           7.2.11.4. Strategic initiatives
                       7.2.12. OraSure Technologies, Inc.
                           7.2.12.1. Company overview
                           7.2.12.2. Financial performance
                           7.2.12.3. Product benchmarking
                           7.2.12.4. Strategic initiatives
                       7.2.13. Quidel Corporation
                           7.2.13.1. Company overview
                           7.2.13.2. Financial performance
                           7.2.13.3. Product benchmarking
                           7.2.13.4. Strategic initiatives
                       7.2.14. Trinity Biotech
                           7.2.14.1. Company overview
                           7.2.14.2. Financial performance
                           7.2.14.3. Product benchmarking
                           7.2.14.4. Strategic initiatives
                       7.2.15. Sekisui Diagnostics
                           7.2.15.1. Company overview
                           7.2.15.2. Financial performance
                           7.2.15.3. Product benchmarking
                           7.2.15.4. Strategic initiatives
                       7.2.16. BD
                           7.2.16.1. Company overview
                           7.2.16.2. Financial performance
                           7.2.16.3. Product benchmarking
                           7.2.16.4. Strategic initiatives


List of Tables

Table 1 List of Abbreviation
Table 2 North America primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 3 North America primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 4 North America primary care POC diagnostics market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 6 U.S. primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 7 Canada primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 8 Canada primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 9 Europe primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 10 Europe primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 11 Europe primary care POC diagnostics market, by region, 2018 - 2030 (USD Million)
Table 12 Germany primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 13 Germany primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 14 UK primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 15 UK primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 16 France primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 17 France primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 18 Italy primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 19 Italy primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 20 Spain primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 21 Spain primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 22 Sweden primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 23 Sweden primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 24 Norway primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 25 Norway primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 26 Denmark primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 27 Denmark primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 28 Asia Pacific primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 29 Asia Pacific primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 30 Asia Pacific primary care POC diagnostics market, by region, 2018 - 2030 (USD Million)
Table 31 China primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 32 China primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 33 Japan primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 34 Japan primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 35 India primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 36 India primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 37 Australia primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 38 Australia primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 39 Thailand primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 40 Thailand primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 41 South Korea primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 42 South Korea primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 43 Latin America primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 44 Latin America primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 45 Latin America primary care POC diagnostics market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 47 Brazil primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 48 Mexico primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 49 Mexico primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 50 Argentina primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 51 Argentina primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa primary care POC diagnostics market, by region, 2018 - 2030 (USD Million)
Table 55 South Africa primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 56 South Africa primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 59 UAE primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 60 UAE primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 61 Kuwait primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
Table 62 Kuwait primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Primary care POC diagnostics: Market outlook
Fig. 9 Primary care POC diagnostics: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Primary care POC diagnostics market driver impact
Fig. 15 Primary care POC diagnostics market restraint impact
Fig. 16 Primary care POC diagnostics market strategic initiatives analysis
Fig. 17 Primary care POC diagnostics market: Product movement analysis
Fig. 18 Primary care POC diagnostics market: Product outlook and key takeaways
Fig. 19 Glucose testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Hb1Ac testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Autoimmune disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Coagulation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Fertility market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Infectious diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Cardiac markers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Thyroid stimulating hormone market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Hematology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Primary care systems market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Decentralized clinical chemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Feces market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Lipid testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Cancer Marker market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Blood gas/electrolytes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Ambulatory chemistry market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Drug abuse testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Urinalysis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Primary care POC diagnostics market: End use movement analysis
Fig. 38 Primary care POC diagnostics market: End use outlook and key takeaways
Fig. 39 Pharmacy & retail clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Physician office market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Urgent care clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Non-practice clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Global primary care POC diagnostics market: Regional movement analysis
Fig. 44 Global primary care POC diagnostics market: Regional outlook and key takeaways
Fig. 45 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon